A class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer is described. Analogs of Mycalolide B have been prepared and tested in breast and ovarian cancer cell lines. The compounds show utility for inhibition of survival and proliferation of tumor cells. The compounds have been shown to disrupt actin.
描述了一类在制药组合物和治疗或预防癌症方法中有用的化合物。已经制备并在乳腺癌和卵巢癌
细胞系中测试了Mycalolide B的类似物。这些化合物显示出抑制肿瘤细胞存活和增殖的效用。已经证明这些化合物会破坏肌动蛋白。